MicroRNA 521-2 (MIR521-2)

MicroRNA 521-2 (MIR521-2) is a member of the microRNA (miRNA) gene family, encoding a short (20–24 nt) non-coding RNA molecule that regulates gene expression via post-transcriptional silencing mechanisms, typically by binding to complementary sequences in target mRNAs, leading to their degradation or inhibition of translation[5][2]. MicroRNAs are broadly involved in diverse biological processes, including development, differentiation, and disease, and their dysregulation can contribute to cancer and other pathologies[2][4]. However, there is currently no published information linking MIR521-2 specifically to a well-characterized mechanism, disease association, or role as a drug target[5]. Summary of limitations: All authoritative sources describe MIR521-2 only as a gene encoding a microRNA molecule, with no evidence for its direct targeting by drugs, direct disease association, or use in patient selection. This molecule should not be classified as a receptor, enzyme, transporter, or classical therapeutic target.

Other names

hsa-mir-521-2MIRN521-2mir-521-2MIR521-2